Third party pharma manufacturing is where the industry is heading. Most companies now scale up through a contract maker and keep their own energy for R&D and marketing. But contract makers differ a lot from one another, and companies keep making the same handful of mistakes when they outsource, mistakes that cost them real money. Get it wrong and you face delays and quality problems, sometimes regulatory trouble on top. Knowing these common mistakes in pharma third party manufacturing, and how to avoid them, is what makes the arrangement work.
What are the Common Mistakes in Pharma Third Party Manufacturing and How to Avoid Them?
1. Failure to Choose the Right Third Party Manufacturer
The first mistake, and the most serious one, is picking the wrong partner for your products. Contract units are not all equally capable. Some don't hold the same standards either, and a bad choice here can hurt your business for years.
How to avoid it
Do your homework on any unit you're considering. Look at its skills and its reputation, and at how well it follows the regulations that apply to you. Start with the certificates: GMP or ISO. Then see whether it has made similar products in your therapy area before. The plant should understand exactly what you need, be it solid dosage forms like tablets, liquids like syrups, or speciality pharma products.
2. Failure in Quality Control Practices
Quality is the backbone of any pharma business. Skip clear, well-defined quality control and the results can be disastrous. Poor quality damages a brand. It can force product recalls and even bring legal action.
How to prevent it
Make sure your contract maker runs tight quality control. Audit and inspect the plant regularly. Spell out your quality expectations in plain terms, and set up proper quality assurance at every stage of production, covering raw material checks and in-process checks right through to testing of the finished product, so that you meet or beat regulatory requirements. Your partner's idea of quality has to match yours.
3. Poor Communication and Documentation
Communication causes more trouble than almost anything else in contract manufacturing. Misunderstandings creep in about timelines or pricing, or about what each side expected, and you end up with delays and frustration on both ends.
How to avoid it
Keep communication clear and constant. Get every agreement in writing, from production timelines to cost structure and product specifications. A detailed contract covering each part of the process, from sourcing raw material to packing and dispatch, heads off most misunderstandings before they start. Schedule regular meetings or updates. That way you can track progress and deal with concerns quickly.
Read More: Why Ayurvedic Products Manufacturing Companies are Growing Worldwide?
4. Underestimating Regulatory Compliance Requirements
Pharma manufacturing is heavily regulated and compliance is not negotiable. A big mistake companies make is assuming their contract partner will handle every regulatory point, without understanding the requirements themselves.
How to avoid it
Work closely with your partner to confirm that all regulatory requirements are being met. Choose a medicine maker whose production standards follow the FDA, the EMA and similar regulatory bodies. The supplier should hold its licence and be certified for what you need. Learn the rules of each country you export to yourself. Coordinate with the manufacturer so you both stay on the right side of the law, because lapses found later are expensive.
5. Having an Overfocus on Cost yet Ignoring the Quality
Cost matters, of course. Where most companies go wrong is chasing the lowest possible price for contract production. That usually ends in poor quality and poor reliability, which costs far more in the long run.
How to avoid it
Think about what dealing with the cheapest unit will mean a year from now. Low prices count, but product quality comes first. The cheapest maker may cut corners to hit its price, and that can badly hurt your reputation and end up costing you more. Balance cost against quality when you decide. Go with a contract manufacturing company that has a history of being trustworthy and making good products.
6. Not Having a Plan for Scaling Production
Another common mistake is not planning for bigger volumes when demand goes up. If your product takes off, you need to be ready.
How to avoid it
Talk about scale-up with your medicine maker from day one. Find out their production capacity and lead times, and whether they can handle larger batches when needed. A strong contract unit should be equipped to grow with you, so if the market suddenly wants more of your finished product, they can get you out of a tight spot. You and the manufacturer both need to understand this clearly, so production can rise on time and still stay cost-effective.
7. Don’t Have any Plan B In Case Of any Supply Chain Event
Supply chain disruption is part of manufacturing. In pharma, it can do real damage. Production stoppages or shortages can bring regulatory penalties and unhappy customers, even safety risks.
How to prevent it
Sit down with your partner and build a contingency plan for supply chain disruption. It should include backup suppliers for critical raw materials. There should be clear channels for reporting delays, and enough flexibility in manufacturing to adjust quickly when things change. A reliable contract partner will already have measures in place to reduce such risks. Still, the two of you need to agree on how you'll handle problems when they come.
8. Not Monitoring Post-Manufacturing Processes
The job doesn't end when the batch comes off the line. Packing, labelling and logistics matter as much as production itself. Don't watch them and you can face delays or wrong labels, and regulatory issues as well.
How to avoid it
Check that your contract maker has a detailed post-manufacturing process. Keep a close eye on packing and labelling, and on distribution, so that everything meets regulatory standards. That means checking the final product for correct labels and expiry dates, and for packaging that is intact. Regular checks keep both quality and compliance in place.
Conclusion
A tie-up with a third party manufacturing company has many advantages. Yet plenty of people make the mistakes above, and those mistakes can wreck a good partnership. Choosing the right partner and communicating clearly go a long way. Add proper quality control and a good grasp of regulatory compliance, and you have a strong partnership. With careful planning and some diligence, your business can enjoy the benefits of contract manufacturing without falling into the traps so many others have.
Some Related Blogs!
What should you know about Common Mistakes in Pharma Third Party Manufacturing and How to Avoid Them?
Third Party Pharma Manufacturing is the trend in the pharma industry, wherein most companies are opting to scale up with third-party manufacturing while they focus more on core areas of R&D and marketing. Different third party manufacturers can vary in several ways, and most of them have common mistakes by which companies lose significantly when they decide to outsource.
Third Party Pharma Manufacturing is the trend in the pharma industry, wherein most companies are opting to scale up with third-party manufacturing while they focus more on core areas of R&D and marketing. Different third party manufacturers can vary in several ways, and most of them have common mistakes by which companies lose significantly when they decide to outsource. Common pitfalls involved in outsourcing manufacturing causes delay, quality issues, and may invite regulatory challenges. Understanding these mistakes and how to avoid them can make sure a Third Party Manufacturing Pharma Company is going to be successful. The first and most critical mistake is not selecting the right Third...
Key takeaways
- What are the Common Mistakes in Pharma Third Party Manufacturing and How to Avoid Them?
- 1. Failure to Choose the Right Third Party Manufacturer
- 2. Failure in Quality Control Practices
- 4. Underestimating Regulatory Compliance Requirements
- 5. Having an Overfocus on Cost yet Ignoring the Quality
- 6. Not Having a Plan for Scaling Production
By the numbers
- India has the highest number of US-FDA compliant manufacturing facilities outside the United States — Invest India, Government of India
- The Indian pharmaceutical market is projected to reach US$ 130 billion by 2030 — IBEF
How to order Common Mistakes in Pharma Third Party Manufacturing and How to Avoid Them
- Define the product Fix the composition, dosage form, pack size, quantity and your brand name.
- Shortlist manufacturers Compare WHO-GMP certification, product permission, capacity and location.
- Compare quotations Ask for the per-unit rate, MOQ, lead time and packing material cost in writing.
- Approve artwork and sample Finalise label, carton and MRP, and approve the pre-production sample.
- Receive your batch Pay the agreed advance and receive goods with invoice and certificate of analysis.
